Ken Powell To Leave Arrow Therapeutics
21-Jan-2009
- United Kingdom
After two years of helping the transition of the small molecule company into a successful antiviral drug discovery and development entity of AZ, Dr. Powell felt the time was right to step down and pursue other interests. Dr. Stuart Cockerill, Research Director, will take over in the interim as Head of Arrow. Stuart joined Arrow from GlaxoSmithKline where he was one of the senior Group Leaders in Medicinal Chemistry.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.